EXEL
Exelixis Inc
NASDAQ: EXEL · HEALTHCARE · BIOTECHNOLOGY
$44.46
-0.51% today
Updated 2026-04-30
Market cap
$11.35B
P/E ratio
16.08
P/S ratio
4.89x
EPS (TTM)
$2.78
Dividend yield
—
52W range
$34 – $50
Volume
2.7M
Exelixis Inc (EXEL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-45.34M | $-68.74M | $-9.76M | $-14.59M | $-101.05M | $-159.23M | $-123.15M | $-198.77M | $-235.41M | $-141.59M | $206.30M | $165.61M | $415.72M | $526.96M | $208.98M | $400.80M | $362.61M | $333.32M | $699.97M | $884.27M |
| Capital expenditures | $11.61M | $17.40M | $15.13M | $5.91M | $1.81M | $991000.00 | $2.72M | $2.17M | $474000.00 | $447000.00 | $1.70M | $21.14M | $33.30M | $12.83M | $30.34M | $64.22M | $138.46M | $162.97M | $66.19M | $39.93M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $17.61M | — | — | $22.91M | $21.11M | $12.10M | $8.83M | $12.03M | $10.01M | $21.98M | $22.91M | $23.94M | $44.32M | $56.60M | $105.07M | $119.82M | $107.57M | $106.34M | $93.84M | $112.98M |
| Free cash flow | $-56.95M | $-86.14M | $-24.89M | $-20.50M | $-102.86M | $-160.22M | $-125.86M | $-200.94M | $-235.88M | $-142.03M | $204.59M | $144.47M | $382.42M | $514.12M | $178.64M | $336.58M | $224.16M | $170.35M | $633.79M | $844.34M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $-23.18M | $95.81M | $-66.09M | $-23.58M | $61.24M | $10.05M | $31.48M | $127.56M | $-47.74M | $52.63M | — | $-161.21M | — | — | — |